PATENT CLAIM ANALYSIS

Application Number: 15914293
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["424", "489000"]

Abstract:
The present invention provides oxygenized nanobubbles and their uses in imaging and cancer treatment when combined with therapeutic drugs and precise ultrasound beam steering.

Claim (Index 12):
Synthesized oxygen nanobubbles (ONBs) for treating non-muscle invasive bladder cancer (NMIBC), said ONBs each consisting of a gaseous molecular oxygen core surrounded by a cellulosic polymer shell, wherein said core-shell structure generates non-uniformity of refractive index to force light to deviate from its linear trajectory to generate light scattering, wherein said synthesized ONBs further comprising at least one chemotherapy drug selected from the group consisting of bacillus Calmette-Guein (BCG) and mitomycin-C (MMC) and said drug is encapsulated within said ONBs.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 90.0
- Lexical Diversity: 1.08696
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14873208', '15691407', '13825941', '14349304', '14692075']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6870133282491632
- 35 USC 102 Novelty (BERT): 0.5279388207261336
- Combined Prediction Score: 0.6711058774968602
- Mean Citation Score: 236.782298
- Max Citation Score: 340.6913
- Similarity Product: 220.3567100619793

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test